During the last session, Upstream Bio Inc (NASDAQ:UPB)’s traded shares were 0.34 million. At the end of the trading day, the stock’s price was $8.94, reflecting an intraday gain of 6.18% or $0.52. The 52-week high for the UPB share is $29.46, that puts it down -229.53 from that peak though still a striking 25.62% gain since the share price plummeted to a 52-week low of $6.65. The company’s market capitalization is $479.15M, and the average trade volume was 329.35K shares over the past three months.

Upstream Bio Inc (NASDAQ:UPB) trade information

Upstream Bio Inc (UPB) registered a 6.18% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 6.18% in intraday trading to $8.94, hitting a weekly high. The stock’s 5-day price performance is 12.74%, and it has moved by -0.89% in 30 days.

The consensus price target of analysts on Wall Street is $75, which implies an increase of 88.08% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $75 and $75 respectively. As a result, UPB is trading at a discount of -738.93% off the target high and -738.93% off the low.

As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 384.75k as predicted by 4 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to 375k by the end of current fiscal year.

While earnings are projected to return 55.26% in 2025, the next five years will return 18.92% per annum.

UPB Dividends

Upstream Bio Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Also, the Mutual Funds coming in first place with the largest holdings of Upstream Bio Inc (UPB) shares are Fidelity Small Cap Growth Fund and Fidelity Select Portfolios – Health Care . Data provided on Dec 31, 2024 indicates that Fidelity Small Cap Growth Fund owns about 1.23 shares. This amounts to just over 2.29 percent of the company’s overall shares, with a $10.97 million market value. The same data shows that the other fund manager holds slightly less at 853.67, or about 1.59% of the stock, which is worth about $7.63 million.